Zepbound offers a scientific approach to weight loss that complements lifestyle adjustments, helping you achieve and maintain your health goals
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated to a maintenance dose of 5, 10, or 15 mg based on individual response
News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
Cellular interplay as a consequence of inflammatory signals leading to liver fibrosis development
People on GLP-1s "can become more sensitive to alcohol, and sugary cocktails can make them feel nauseated," George told me
Deep belly fat isnt just something we notice on the surface